# Kermode Biotechnologies Inc. — Form D

Kermode Biotechnologies Inc. of ERIE, CO, a company, filed a Form D exempt-offering notice with the SEC on 2021-05-21. The offering totals $1.5M, of which $1.2M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2021-05-21
- Form: D
- Accession: 0001863649-21-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $1.5M
- Amount sold: $1.2M
- Remaining: $300K
- Minimum investment: $100K
- Investors: 4
- Date of first sale: 2021-01-31
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-400263

## Issuer

- Name: Kermode Biotechnologies Inc.
- CIK: 0001863649
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2019
- Address: 1399 GLENARM COURT, ERIE, CO, 80516
- Phone: 70-618-9555

## Officers, directors & promoters (4)

| Name | Role | Location |
| --- | --- | --- |
| Dalu (Dan) Chen | Director | Erie, CO |
| Thomas Malcolm | Director | Andover, NJ |
| Dalu (Dan) Chen | Executive Officer | Erie, CO |
| Thomas Malcolm | Executive Officer | Andover, NJ |

## More

- [CIK 1863649 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1863649&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001863649-21-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.